Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 583-586, May 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barranco, S. C.
Right arrow Articles by Humphrey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barranco, S. C.
Right arrow Articles by Humphrey, R. M.

The Effects of ß-2'-Deoxythioguanosine on Survival and Progression in Mammalian Cells1

S. C. Barranco and R. M. Humphrey

Section of Cellular Studies, Department of Physics, University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77025

Synchronized Chinese hamster ovary cells were most sensitive to ß-2'-deoxythioguanosine (ß-TGdR) in early and mid S phase. However, little effect on DNA synthesis was observed. One possible mechanism that could account for cell lethality in S-phase cells would be errors made in DNA replication subsequent to incorporation of ß-TGdR into DNA. Mitotic cells were totally unaffected and G1 cells were only slightly sensitive to ß-TGdR. Treatment with ß-TGdR did not cause progression or division delay, even when cells were treated in early and mid S phase when survival was reduced to 11%.

1 This work was supported in part by NIH Grants CA 05099 and CA 04484.

Received 12/ 3/70. Accepted 1/22/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.